Connor, Clark & Lunn Investment Management (CC&L)’s Ambev ABEV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEV
SCP
NAMI
BIP
ETC
Connor, Clark & Lunn Investment Management (CC&L)'s ABEV Position: Q2 2026 in Review
Connor, Clark & Lunn Investment Management (CC&L) increased its Ambev (ABEV) stake by 1,990% in Q2 2026, buying an estimated $1.37M and bringing the position to 460,355 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #1095.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ABEV in Q4 2017 and has held it in 26 quarters since. The position peaked at $7.77M in Q3 2022. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.
- Connor, Clark & Lunn Investment Management (CC&L) held 460,355 shares of Ambev worth $1.45M as of Q2 2026.
- Connor, Clark & Lunn Investment Management (CC&L) bought 438,324 Ambev shares in Q2 2026, an estimated $1.37M.
- Ambev made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #1095 holding.
- Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Ambev in Q4 2017 and has held it in 26 quarters since.
- Connor, Clark & Lunn Investment Management (CC&L)'s Ambev position peaked at $7.77M in Q3 2022.
- 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.